jamanetwork.com Wegovy (semaglutide) prescribing information
The FDA signaled new limits on non-approved compounded GLP-1 APIs being mass-marketed, and it explicitly called out Hims
Dialysis is a prohibited method under M1.1, as blood is taken out from the patient and filtered, before being reintroduced back into the patients circulatory system
In a recent study published in The Lancet Diabetes Endocrinology , researchers evaluate the effects of glucagon-like peptide-1 (GLP-1) receptor agonists on kidney and cardiovascular outcomes
They increase the release of the signals that suppress appetite, which reduces cravings, and also delay gastric emptying, so youre actually fuller longer and dont feel the need to keep eating
Safety and side effects: A meta-analysis of multiple studies in COPD patients showed no significant adverse effects at doses ranging from 600 mg to 3g/day.[ref] Studies in healthy adult athletes go up to 20g/day (not recommending this, just including it for safety).[ref] Conversely, in Parkinsons patients, there was a high number of adverse events at 6g/day of NAC